Piretanide/Ramipril

吡咯他尼/雷米普利

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePiretanide/Ramipril
Drug Alias Name雷米普利吡咯他尼Ramipril and Piretanide吡咯他尼雷米普利Piretanide and RamiprilRamipril/Piretanide +[9] 
ClassificationSmall molecules
Mechanisms of ActionSodium-(potassium)-chloride cotransporter 2 inhibitorsAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzymeSodium-(potassium)-chloride cotransporter 2
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2000/01/01
Country/TerritoryN/A
CombinationsYes PiretanideRamipril
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeC02N
Related LinksN/A